<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p116" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_116{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t2_116{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t3_116{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t4_116{left:341px;bottom:30px;}
#t5_116{left:348px;bottom:25px;letter-spacing:0.11px;}
#t6_116{left:377px;bottom:30px;}
#t7_116{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t8_116{left:540px;bottom:30px;}
#t9_116{left:546px;bottom:25px;letter-spacing:0.07px;}
#ta_116{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#tb_116{left:44px;bottom:63px;letter-spacing:0.1px;}
#tc_116{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_116{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_116{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_116{left:1108px;bottom:47px;letter-spacing:0.36px;}
#tg_116{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_116{left:300px;bottom:778px;letter-spacing:0.42px;word-spacing:-0.35px;}
#ti_116{left:891px;bottom:786px;letter-spacing:-0.12px;}
#tj_116{left:36px;bottom:282px;}
#tk_116{left:46px;bottom:276px;letter-spacing:0.1px;word-spacing:-0.08px;}
#tl_116{left:45px;bottom:261px;letter-spacing:0.13px;}
#tm_116{left:36px;bottom:252px;}
#tn_116{left:46px;bottom:246px;letter-spacing:0.13px;}
#to_116{left:45px;bottom:231px;letter-spacing:0.13px;}
#tp_116{left:45px;bottom:215px;letter-spacing:0.13px;}
#tq_116{left:45px;bottom:200px;letter-spacing:0.08px;word-spacing:0.04px;}
#tr_116{left:36px;bottom:191px;}
#ts_116{left:46px;bottom:185px;letter-spacing:0.09px;word-spacing:-0.02px;}
#tt_116{left:45px;bottom:170px;letter-spacing:0.12px;}
#tu_116{left:45px;bottom:154px;letter-spacing:0.12px;}
#tv_116{left:36px;bottom:145px;}
#tw_116{left:46px;bottom:139px;letter-spacing:0.06px;word-spacing:0.02px;}
#tx_116{left:45px;bottom:124px;letter-spacing:0.12px;}
#ty_116{left:45px;bottom:108px;letter-spacing:0.1px;word-spacing:0.03px;}
#tz_116{left:36px;bottom:757px;letter-spacing:-0.09px;}
#t10_116{left:36px;bottom:738px;letter-spacing:-0.09px;}
#t11_116{left:36px;bottom:720px;letter-spacing:-0.1px;word-spacing:-0.03px;}
#t12_116{left:36px;bottom:702px;letter-spacing:-0.09px;}
#t13_116{left:36px;bottom:683px;letter-spacing:-0.09px;}
#t14_116{left:615px;bottom:269px;}
#t15_116{left:625px;bottom:263px;letter-spacing:0.09px;word-spacing:-0.03px;}
#t16_116{left:624px;bottom:247px;letter-spacing:0.12px;}
#t17_116{left:624px;bottom:231px;letter-spacing:0.1px;word-spacing:0.03px;}
#t18_116{left:615px;bottom:221px;}
#t19_116{left:625px;bottom:215px;letter-spacing:0.12px;}
#t1a_116{left:624px;bottom:200px;letter-spacing:0.12px;}
#t1b_116{left:624px;bottom:185px;letter-spacing:0.12px;}
#t1c_116{left:624px;bottom:170px;letter-spacing:0.13px;}
#t1d_116{left:615px;bottom:160px;}
#t1e_116{left:625px;bottom:154px;letter-spacing:0.09px;word-spacing:0.01px;}
#t1f_116{left:624px;bottom:139px;letter-spacing:0.13px;}
#t1g_116{left:624px;bottom:124px;letter-spacing:0.12px;word-spacing:-0.17px;}
#t1h_116{left:624px;bottom:108px;letter-spacing:0.14px;}
#t1i_116{left:1091px;bottom:83px;letter-spacing:-0.11px;}
#t1j_116{left:36px;bottom:663px;letter-spacing:-0.11px;}
#t1k_116{left:36px;bottom:646px;letter-spacing:-0.08px;}
#t1l_116{left:42px;bottom:629px;}
#t1m_116{left:58px;bottom:629px;letter-spacing:-0.26px;}
#t1n_116{left:58px;bottom:612px;letter-spacing:-0.26px;}
#t1o_116{left:58px;bottom:595px;letter-spacing:-0.26px;}
#t1p_116{left:58px;bottom:578px;letter-spacing:-0.26px;}
#t1q_116{left:58px;bottom:562px;letter-spacing:-0.25px;word-spacing:-0.11px;}
#t1r_116{left:58px;bottom:545px;letter-spacing:-0.26px;}
#t1s_116{left:58px;bottom:528px;letter-spacing:-0.26px;}
#t1t_116{left:58px;bottom:511px;letter-spacing:-0.26px;word-spacing:-0.12px;}
#t1u_116{left:58px;bottom:494px;letter-spacing:-0.26px;}
#t1v_116{left:58px;bottom:478px;letter-spacing:-0.25px;}
#t1w_116{left:42px;bottom:461px;}
#t1x_116{left:59px;bottom:461px;letter-spacing:-0.09px;}
#t1y_116{left:58px;bottom:444px;letter-spacing:-0.09px;}
#t1z_116{left:58px;bottom:427px;letter-spacing:-0.09px;word-spacing:-0.09px;}
#t20_116{left:58px;bottom:410px;letter-spacing:-0.09px;}
#t21_116{left:58px;bottom:394px;letter-spacing:-0.09px;}
#t22_116{left:58px;bottom:377px;letter-spacing:-0.09px;}
#t23_116{left:58px;bottom:360px;letter-spacing:-0.09px;}
#t24_116{left:58px;bottom:343px;letter-spacing:-0.09px;}
#t25_116{left:58px;bottom:326px;letter-spacing:-0.09px;}
#t26_116{left:610px;bottom:661px;letter-spacing:-0.1px;}
#t27_116{left:616px;bottom:645px;}
#t28_116{left:632px;bottom:645px;letter-spacing:-0.11px;word-spacing:0.01px;}
#t29_116{left:632px;bottom:628px;letter-spacing:-0.1px;}
#t2a_116{left:638px;bottom:611px;letter-spacing:-0.09px;}
#t2b_116{left:638px;bottom:594px;letter-spacing:-0.09px;}
#t2c_116{left:638px;bottom:577px;letter-spacing:-0.09px;}
#t2d_116{left:616px;bottom:561px;}
#t2e_116{left:632px;bottom:561px;letter-spacing:-0.09px;}
#t2f_116{left:632px;bottom:544px;letter-spacing:-0.1px;}
#t2g_116{left:632px;bottom:527px;letter-spacing:-0.1px;}
#t2h_116{left:632px;bottom:510px;letter-spacing:-0.09px;}
#t2i_116{left:632px;bottom:493px;letter-spacing:-0.1px;}
#t2j_116{left:632px;bottom:477px;letter-spacing:-0.1px;}
#t2k_116{left:632px;bottom:458px;letter-spacing:-0.1px;}
#t2l_116{left:958px;bottom:458px;letter-spacing:-0.23px;word-spacing:0.13px;}
#t2m_116{left:632px;bottom:440px;letter-spacing:-0.1px;}
#t2n_116{left:906px;bottom:440px;letter-spacing:-0.09px;}
#t2o_116{left:632px;bottom:423px;letter-spacing:-0.09px;}
#t2p_116{left:632px;bottom:406px;letter-spacing:-0.09px;}
#t2q_116{left:632px;bottom:390px;letter-spacing:-0.09px;}
#t2r_116{left:632px;bottom:373px;letter-spacing:-0.09px;}
#t2s_116{left:610px;bottom:349px;letter-spacing:-0.09px;}
#t2t_116{left:616px;bottom:332px;}
#t2u_116{left:632px;bottom:332px;letter-spacing:-0.09px;}
#t2v_116{left:632px;bottom:315px;letter-spacing:-0.1px;}
#t2w_116{left:739px;bottom:323px;}
#t2x_116{left:747px;bottom:315px;letter-spacing:-0.09px;}
#t2y_116{left:851px;bottom:323px;}
#t2z_116{left:863px;bottom:315px;letter-spacing:-0.1px;}
#t30_116{left:932px;bottom:323px;letter-spacing:-0.12px;}
#t31_116{left:956px;bottom:315px;letter-spacing:-0.1px;}
#t32_116{left:632px;bottom:299px;letter-spacing:-0.1px;}
#t33_116{left:866px;bottom:306px;}
#t34_116{left:879px;bottom:299px;letter-spacing:-0.08px;}
#t35_116{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_116{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_116{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s2_116{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s3_116{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_116{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_116{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_116{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s7_116{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s8_116{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_116{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sa_116{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sb_116{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.sc_116{font-size:17px;font-family:Webdings_k6;color:#000;}
.sd_116{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts116" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg116Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg116" style="-webkit-user-select: none;"><object width="1210" height="935" data="116/116.svg" type="image/svg+xml" id="pdf116" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_116" class="t s0_116">NCCN Guidelines Version 4.2024 </span>
<span id="t2_116" class="t s0_116">Head and Neck Cancers </span>
<span id="t3_116" class="t s1_116">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t4_116" class="t s2_116">® </span>
<span id="t5_116" class="t s1_116">(NCCN </span>
<span id="t6_116" class="t s2_116">® </span>
<span id="t7_116" class="t s1_116">), All rights reserved. NCCN Guidelines </span>
<span id="t8_116" class="t s2_116">® </span>
<span id="t9_116" class="t s1_116">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="ta_116" class="t s3_116">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="tb_116" class="t s3_116">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="tc_116" class="t s4_116">NCCN Guidelines Index </span>
<span id="td_116" class="t s4_116">Table of Contents </span>
<span id="te_116" class="t s4_116">Discussion </span>
<span id="tf_116" class="t s5_116">NUTR-A </span>
<span id="tg_116" class="t s5_116">1 OF 2 </span>
<span id="th_116" class="t s5_116">PRINCIPLES OF NUTRITION: MANAGEMENT AND SUPPORTIVE CARE </span>
<span id="ti_116" class="t s6_116">1-3 </span>
<span id="tj_116" class="t s7_116">1 </span>
<span id="tk_116" class="t s8_116">Ehrsson YT, Langius-Eklöf A, Laurell G. Nutritional surveillance and weight loss in </span>
<span id="tl_116" class="t s8_116">head and neck cancer patients. Support Care Cancer 2012;20:757-765. </span>
<span id="tm_116" class="t s7_116">2 </span>
<span id="tn_116" class="t s8_116">Locher JL, Bonner JA, Carroll WR, et al. Prophylactic percutaneous endoscopic </span>
<span id="to_116" class="t s8_116">gastrostomy tube placement in treatment of head and neck cancer: a </span>
<span id="tp_116" class="t s8_116">comprehensive review and call for evidence-based medicine. JPEN J Parenter </span>
<span id="tq_116" class="t s8_116">Enteral Nutr 2011;35:365-374. </span>
<span id="tr_116" class="t s7_116">3 </span>
<span id="ts_116" class="t s8_116">Langius JA, van Dijk AM, Doornaert P, et al. More than 10% weight loss in head </span>
<span id="tt_116" class="t s8_116">and neck cancer patients during radiotherapy is independently associated with </span>
<span id="tu_116" class="t s8_116">deterioration in quality of life. Nutr Cancer 2013;65:76-83. </span>
<span id="tv_116" class="t s7_116">4 </span>
<span id="tw_116" class="t s8_116">Lefebvre T, Tack L, Lycke M, et al. Effectiveness of adjunctive analgesics in head </span>
<span id="tx_116" class="t s8_116">and neck cancer patients receiving curative (chemo-) radiotherapy: a systematic </span>
<span id="ty_116" class="t s8_116">review. Pain Med 2021;22:152-164. </span>
<span id="tz_116" class="t s5_116">Most patients with head and neck cancer lose weight and are nutritionally compromised as a result of their disease, health behaviors, and </span>
<span id="t10_116" class="t s5_116">treatment-related toxicities. Nutritional management is very important in patients with head and neck cancer to improve outcomes and to </span>
<span id="t11_116" class="t s9_116" data-mappings='[[14,"fi"]]'>minimize signiﬁcant temporary or permanent treatment-related complications (eg, severe weight loss). A registered dietitian and a speech </span>
<span id="t12_116" class="t s5_116">language/swallowing therapist should be part of the multidisciplinary team for treating patients with head and neck cancer throughout the </span>
<span id="t13_116" class="t s5_116">continuum of care. </span>
<span id="t14_116" class="t s7_116">5 </span>
<span id="t15_116" class="t s8_116">Bar Ad V, Weinstein G, Dutta PR, et al. Gabapentin for the treatment of pain </span>
<span id="t16_116" class="t s8_116">syndrome related to radiation-induced mucositis in patients with head and neck </span>
<span id="t17_116" class="t s8_116">cancer treated with concurrent chemoradiotherapy. Cancer 2010;116:4206-4213. </span>
<span id="t18_116" class="t s7_116">6 </span>
<span id="t19_116" class="t s8_116">Leenstra JL, Miller RC, Qin R, et al. Doxepin rinse versus placebo in the </span>
<span id="t1a_116" class="t s8_116">treatment of acute oral mucositis pain in patients receiving head and neck </span>
<span id="t1b_116" class="t sa_116">radiotherapy with or without chemotherapy: a phase III, randomized, double-blind </span>
<span id="t1c_116" class="t s8_116">trial (NCCTG-N09C6 [Alliance]). J Clin Oncol 2014;32:1571-1577. </span>
<span id="t1d_116" class="t s7_116">7 </span>
<span id="t1e_116" class="t s8_116">Sio TT, Le-Rademacher JG, Leenstra JL, et al. Effect of doxepin mouthwash </span>
<span id="t1f_116" class="t s8_116">or diphenhydramine-lidocaine-antacid mouthwash vs placebo on radiotherapy- </span>
<span id="t1g_116" class="t sa_116">related oral mucositis pain: the Alliance A221304 randomized clinical trial. JAMA </span>
<span id="t1h_116" class="t s8_116">2019;321:1481-1490. </span>
<span id="t1i_116" class="t sb_116">Continued </span>
<span id="t1j_116" class="t s5_116">Assessment and Management </span>
<span id="t1k_116" class="t s5_116">• Nutrition </span>
<span id="t1l_116" class="t sc_116"></span><span id="t1m_116" class="t s5_116">Close monitoring of nutritional status is recommended in </span>
<span id="t1n_116" class="t s9_116" data-mappings='[[27,"fi"]]'>patients who have: 1) signiﬁcant weight loss (5% weight loss </span>
<span id="t1o_116" class="t s5_116">over prior 1 month, or 10% weight loss over 6 months); and/or 2) </span>
<span id="t1p_116" class="t s9_116" data-mappings='[[2,"ffi"]]'>diﬃculty swallowing because of pain or tumor involvement prior </span>
<span id="t1q_116" class="t s5_116">to treatment. All patients should be evaluated for nutritional risks </span>
<span id="t1r_116" class="t s5_116">and should receive nutrition counseling by a registered dietitian </span>
<span id="t1s_116" class="t s5_116">and/or indicated treatment with various nutrition interventions, </span>
<span id="t1t_116" class="t s5_116">such as feeding tubes (eg, nasogastric [NG] tubes, percutaneous </span>
<span id="t1u_116" class="t s5_116">endoscopic gastrostomy [PEG] tubes) or intravenous nutrition </span>
<span id="t1v_116" class="t s5_116">support (but only if enteral support is not feasible). </span>
<span id="t1w_116" class="t sc_116"></span><span id="t1x_116" class="t s5_116">Pre- and post-treatment functional evaluation including </span>
<span id="t1y_116" class="t s5_116">nutritional status should be undertaken using subjective </span>
<span id="t1z_116" class="t s5_116">and objective assessment tools. All patients should receive </span>
<span id="t20_116" class="t s5_116">dietary counseling with the initiation of treatment, especially </span>
<span id="t21_116" class="t s5_116">with radiotherapy-based treatments. Regular follow-up with </span>
<span id="t22_116" class="t s5_116">the registered dietitian should continue at least until the </span>
<span id="t23_116" class="t s5_116">patient has achieved a nutritionally stable baseline following </span>
<span id="t24_116" class="t s5_116">treatment. For some patients with chronic nutritional </span>
<span id="t25_116" class="t s5_116">challenges, this follow-up should be ongoing. </span>
<span id="t26_116" class="t s5_116">• Speech and Swallowing </span>
<span id="t27_116" class="t sc_116"></span><span id="t28_116" class="t s5_116">A formal speech and swallowing evaluation at baseline is </span>
<span id="t29_116" class="t s5_116">recommended for either: </span>
<span id="t2a_116" class="t s5_116">1) patients with speech and/or swallowing dysfunction; or </span>
<span id="t2b_116" class="t s9_116" data-mappings='[[42,"ff"]]'>2) patients whose treatment is likely to aﬀect speech and/or </span>
<span id="t2c_116" class="t s5_116">swallowing. </span>
<span id="t2d_116" class="t sc_116"></span><span id="t2e_116" class="t s5_116">Patients with ongoing abnormal function should be seen regularly </span>
<span id="t2f_116" class="t s5_116">by speech-language pathologists. Dysphagia and swallowing </span>
<span id="t2g_116" class="t s5_116">function can be measured by clinical swallowing assessments </span>
<span id="t2h_116" class="t s9_116" data-mappings='[[11,"fl"]]'>or by videoﬂuoroscopic swallowing studies. Patient evaluations </span>
<span id="t2i_116" class="t s5_116">should also include assessment for any changes in speech and </span>
<span id="t2j_116" class="t s5_116">communication; changes in taste; and assessment for xerostomia, </span>
<span id="t2k_116" class="t s9_116" data-mappings='[[31,"fi"]]'>pain, trismus, lymphedema, and ﬁbrosis </span><span id="t2l_116" class="t s5_116">(see SLYMPH-A in the </span>
<span id="t2m_116" class="t sb_116">NCCN Guidelines for Survivorship</span><span id="t2n_116" class="t s5_116">). Follow-up with the speech- </span>
<span id="t2o_116" class="t s5_116">language pathologist should continue at least until the patient has </span>
<span id="t2p_116" class="t s5_116">achieved a stable baseline following treatment. For some patients </span>
<span id="t2q_116" class="t s5_116">with chronic speech and swallowing challenges, this follow-up may </span>
<span id="t2r_116" class="t s9_116" data-mappings='[[15,"fi"]]'>need to be indeﬁnite. </span>
<span id="t2s_116" class="t s5_116">• Pain </span>
<span id="t2t_116" class="t sc_116"></span><span id="t2u_116" class="t s5_116">Assess pain from oral mucositis and prescribe pregabalin </span>
<span id="t2v_116" class="t s5_116">(category 2B) </span>
<span id="t2w_116" class="t s6_116">4 </span>
<span id="t2x_116" class="t s5_116">, gabapentin, </span>
<span id="t2y_116" class="t s6_116">5 </span>
<span id="t2z_116" class="t s5_116">doxepin, </span>
<span id="t30_116" class="t s6_116">6,7 </span>
<span id="t31_116" class="t s5_116">or diphenhydramine/ </span>
<span id="t32_116" class="t s5_116">lidocaine/antacid mouthwash </span>
<span id="t33_116" class="t s6_116">6 </span>
<span id="t34_116" class="t s5_116">as clinically indicated. </span>
<span id="t35_116" class="t sd_116">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
